Cross-sectional analysis highlights higher rates of antimicrobial resistance in uropathogens among diabetic patients, suggesting implications for UTI treatment.
Key Points
Patients with diabetes exhibit higher rates of antimicrobial resistance, especially in E. coli.
Infections caused by E. coli show multidrug resistance; 30.5% in uncomplicated UTIs and up to 61.8% in complicated UTIs.
The study categorized patients into uncomplicated and complicated UTIs, analyzing resistance profiles within each group.
Stratifying individuals by diabetes status may improve treatment strategies and reduce overall antimicrobial resistance.